A citation-based method for searching scientific literature

R J MacInnis, A Bickerstaffe, C Apicella, G S Dite, J G Dowty, K Aujard, K-A Phillips, P Weideman, A Lee, M B Terry, G G Giles, M C Southey, A C Antoniou, J L Hopper. Br J Cancer 2013
Times Cited: 32







List of co-cited articles
154 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.
A C Antoniou, A P Cunningham, J Peto, D G Evans, F Lalloo, S A Narod, H A Risch, J E Eyfjord, J L Hopper, M C Southey,[...]. Br J Cancer 2008
314
40

A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
684
40

The BOADICEA model of genetic susceptibility to breast and ovarian cancer.
A C Antoniou, P P D Pharoah, P Smith, D F Easton. Br J Cancer 2004
294
37

Large-scale genotyping identifies 41 new loci associated with breast cancer risk.
Kyriaki Michailidou, Per Hall, Anna Gonzalez-Neira, Maya Ghoussaini, Joe Dennis, Roger L Milne, Marjanka K Schmidt, Jenny Chang-Claude, Stig E Bojesen, Manjeet K Bolla,[...]. Nat Genet 2013
778
28

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
28

BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface.
A J Lee, A P Cunningham, K B Kuchenbaecker, N Mavaddat, D F Easton, A C Antoniou. Br J Cancer 2014
138
28

Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance.
Anne S Quante, Alice S Whittemore, Tom Shriver, Konstantin Strauch, Mary B Terry. Breast Cancer Res 2012
71
25


The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer.
Esther M John, John L Hopper, Jeanne C Beck, Julia A Knight, Susan L Neuhausen, Ruby T Senie, Argyrios Ziogas, Irene L Andrulis, Hoda Anton-Culver, Norman Boyd,[...]. Breast Cancer Res 2004
235
25

Assessing women at high risk of breast cancer: a review of risk assessment models.
Eitan Amir, Orit C Freedman, Bostjan Seruga, D Gareth Evans. J Natl Cancer Inst 2010
269
21

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
18

Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consortium.
Christine Fischer, Karoline Kuchenbäcker, Christoph Engel, Silke Zachariae, Kerstin Rhiem, Alfons Meindl, Nils Rahner, Nicola Dikow, Hansjörg Plendl, Irmgard Debatin,[...]. J Med Genet 2013
50
18

Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme.
E Amir, D G Evans, A Shenton, F Lalloo, A Moran, C Boggis, M Wilson, A Howell. J Med Genet 2003
186
18

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
Debbie Saslow, Carla Boetes, Wylie Burke, Steven Harms, Martin O Leach, Constance D Lehman, Elizabeth Morris, Etta Pisano, Mitchell Schnall, Stephen Sener,[...]. CA Cancer J Clin 2007
18

Practical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk.
Anne S Quante, Alice S Whittemore, Tom Shriver, John L Hopper, Konstantin Strauch, Mary Beth Terry. J Natl Cancer Inst 2015
28
21

Prediction of breast cancer risk based on profiling with common genetic variants.
Nasim Mavaddat, Paul D P Pharoah, Kyriaki Michailidou, Jonathan Tyrer, Mark N Brook, Manjeet K Bolla, Qin Wang, Joe Dennis, Alison M Dunning, Mitul Shah,[...]. J Natl Cancer Inst 2015
318
18

Cohort Profile: The Breast Cancer Prospective Family Study Cohort (ProF-SC).
Mary Beth Terry, Kelly-Anne Phillips, Mary B Daly, Esther M John, Irene L Andrulis, Saundra S Buys, David E Goldgar, Julia A Knight, Alice S Whittemore, Wendy K Chung,[...]. Int J Epidemiol 2016
38
18

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial.
Jack Cuzick, Ivana Sestak, John F Forbes, Mitch Dowsett, Jill Knox, Simon Cawthorn, Christobel Saunders, Nicola Roche, Robert E Mansel, Gunter von Minckwitz,[...]. Lancet 2014
347
15

Validation studies for models projecting the risk of invasive and total breast cancer incidence.
J P Costantino, M H Gail, D Pee, S Anderson, C K Redmond, J Benichou, H S Wieand. J Natl Cancer Inst 1999
504
15

Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data.
Jack Cuzick, Ivana Sestak, Bernardo Bonanni, Joseph P Costantino, Steve Cummings, Andrea DeCensi, Mitch Dowsett, John F Forbes, Leslie Ford, Andrea Z LaCroix,[...]. Lancet 2013
274
15

Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
529
15

Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model.
Andrew J Lee, Alex P Cunningham, Marc Tischkowitz, Jacques Simard, Paul D Pharoah, Douglas F Easton, Antonis C Antoniou. Genet Med 2016
51
15

Clinical software development for the Web: lessons learned from the BOADICEA project.
Alex P Cunningham, Antonis C Antoniou, Douglas F Easton. BMC Med Inform Decis Mak 2012
8
50

Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics.
A C Antoniou, R Hardy, L Walker, D G Evans, A Shenton, R Eeles, S Shanley, G Pichert, L Izatt, S Rose,[...]. J Med Genet 2008
129
12

Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer.
Anne Kinhult Ståhlbom, Hemming Johansson, Annelie Liljegren, Anna von Wachenfeldt, Brita Arver. Fam Cancer 2012
13
30

Polygenes, risk prediction, and targeted prevention of breast cancer.
Paul D P Pharoah, Antonis C Antoniou, Douglas F Easton, Bruce A J Ponder. N Engl J Med 2008
402
12

Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline.
Kala Visvanathan, Patricia Hurley, Elissa Bantug, Powel Brown, Nananda F Col, Jack Cuzick, Nancy E Davidson, Andrea Decensi, Carol Fabian, Leslie Ford,[...]. J Clin Oncol 2013
205
12

Breast cancer risk prediction accuracy in Jewish Israeli high-risk women using the BOADICEA and IBIS risk models.
Yael Laitman, Monica Simeonov, Lital Keinan-Boker, Irena Liphshitz, Eitan Friedman. Genet Res (Camb) 2013
10
40


Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort.
Kelly-Anne Phillips, Phyllis N Butow, Ailsa E Stewart, Jiun-Horng Chang, Prue C Weideman, Melanie A Price, Sue Anne McLachlan, Geoffrey J Lindeman, Michael J McKay, Michael L Friedlander,[...]. Fam Cancer 2005
46
12

BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors.
Andrew Lee, Nasim Mavaddat, Amber N Wilcox, Alex P Cunningham, Tim Carver, Simon Hartley, Chantal Babb de Villiers, Angel Izquierdo, Jacques Simard, Marjanka K Schmidt,[...]. Genet Med 2019
166
12

Genome-wide association studies identify four ER negative-specific breast cancer risk loci.
Montserrat Garcia-Closas, Fergus J Couch, Sara Lindstrom, Kyriaki Michailidou, Marjanka K Schmidt, Mark N Brook, Nick Orr, Suhn Kyong Rhie, Elio Riboli, Heather S Feigelson,[...]. Nat Genet 2013
309
9

Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors.
Bronson D Riley, Julie O Culver, Cécile Skrzynia, Leigha A Senter, June A Peters, Josephine W Costalas, Faith Callif-Daley, Sherry C Grumet, Katherine S Hunt, Rebecca S Nagy,[...]. J Genet Couns 2012
194
9

Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.
Suzanne A Eccles, Eric O Aboagye, Simak Ali, Annie S Anderson, Jo Armes, Fedor Berditchevski, Jeremy P Blaydes, Keith Brennan, Nicola J Brown, Helen E Bryant,[...]. Breast Cancer Res 2013
235
9

Assessing breast cancer risk models in Marin County, a population with high rates of delayed childbirth.
Mark Powell, Farid Jamshidian, Kate Cheyne, Joanne Nititham, Lee Ann Prebil, Rochelle Ereman. Clin Breast Cancer 2014
12
25

Performance of common genetic variants in breast-cancer risk models.
Sholom Wacholder, Patricia Hartge, Ross Prentice, Montserrat Garcia-Closas, Heather Spencer Feigelson, W Ryan Diver, Michael J Thun, David G Cox, Susan E Hankinson, Peter Kraft,[...]. N Engl J Med 2010
323
9

A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance.
Catherine Meads, Ikhlaaq Ahmed, Richard D Riley. Breast Cancer Res Treat 2012
103
9

Breast cancer risk assessment in 8,824 women attending a family history evaluation and screening programme.
D Gareth R Evans, Sarah Ingham, Sarah Dawe, L Roberts, F Lalloo, A R Brentnall, P Stavrinos, Anthony Howell. Fam Cancer 2014
15
20

Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information.
Matthew E Mealiffe, Renee P Stokowski, Brian K Rhees, Ross L Prentice, Mary Pettinger, David A Hinds. J Natl Cancer Inst 2010
119
9

Exemestane for breast-cancer prevention in postmenopausal women.
Paul E Goss, James N Ingle, José E Alés-Martínez, Angela M Cheung, Rowan T Chlebowski, Jean Wactawski-Wende, Anne McTiernan, John Robbins, Karen C Johnson, Lisa W Martin,[...]. N Engl J Med 2011
570
9


Using SNP genotypes to improve the discrimination of a simple breast cancer risk prediction model.
Gillian S Dite, Maryam Mahmoodi, Adrian Bickerstaffe, Fleur Hammet, Robert J Macinnis, Helen Tsimiklis, James G Dowty, Carmel Apicella, Kelly-Anne Phillips, Graham G Giles,[...]. Breast Cancer Res Treat 2013
26
11


BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research.
Susan L Neuhausen, Hilmi Ozcelik, Melissa C Southey, Esther M John, Andrew K Godwin, Wendy Chung, Jeniffer Iriondo-Perez, Alexander Miron, Regina M Santella, Alice Whittemore,[...]. Breast Cancer Res Treat 2009
46
9


Genetic susceptibility to breast cancer.
Nasim Mavaddat, Antonis C Antoniou, Douglas F Easton, Montserrat Garcia-Closas. Mol Oncol 2010
215
9



Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers.
M T Mandelson, N Oestreicher, P L Porter, D White, C A Finder, S H Taplin, E White. J Natl Cancer Inst 2000
647
9

Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention.
B Rockhill, D Spiegelman, C Byrne, D J Hunter, G A Colditz. J Natl Cancer Inst 2001
422
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.